In this elaborative study, we have revealed limitations of using classical data analysis approaches to determine the diagnostic utility of the cytokine IL-37 in older patients with T2D, and we have laid a foundation for introducing new methodology approaches. This evidence concerns the gene IL37 and type 2 diabetes mellitus.